Parallel Advisors, LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 28 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,015,966
-27.7%
1,693,5590.0%0.03%
-24.4%
Q2 2023$1,405,993
+135.4%
1,693,5590.0%0.04%
+125.0%
Q1 2023$597,318
-17.5%
1,693,5590.0%0.02%
-35.5%
Q4 2022$724,166
-25.3%
1,693,5590.0%0.03%
-31.1%
Q3 2022$969,000
-59.7%
1,693,5590.0%0.04%
-59.1%
Q2 2022$2,405,000
-12.4%
1,693,559
+150.0%
0.11%
+0.9%
Q1 2022$2,744,000677,4520.11%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders